CapEdge
Loading...
Advanced
What's new? Log in Free sign up
  • Home
  • Sectors & IndustriesSectors
  • Earnings
  • IPOs
  • SPACs
  • Transcripts
  • Insider
  • Institutional
  • Crypto
  • Screeners
  • Reddit
  • Splits
  • ACCD Dashboard
  • Financials
  • Filings
  • Transcripts
  • ETFs
  • Insider
  • Institutional
  • Shorts
  • News
  • Patents
  • Reddit

Accolade (ACCD)

Company Profile
Accolade, Inc. of Pennsylvania provides healthcare related information for self-insured companies. The Company assists employees and their families to make healthcare decisions through its health assistants. Accolade serves customers in the United States.
Accolade logo

Company profile

Ticker
ACCD
Exchange
NASDAQ
Website
www.accolade.com
CEO
Rajeev Singh
Employees
Incorporated
Delaware
Location
Pennsylvania
Fiscal year end
Feb 28
Sector
Information > All Other Information Services
Industry (SIC)
Services - Business Services, NEC
Alibaba Group Holding • EBay • Visa • DiDi Global • Uber • PayPal • Accenture • Nielsen • Mastercard • Bread Financial ...
Former names
Accolade LLC
SEC CIK
0001481646
Corporate docs
Articles of Incorporation & Bylaws
Underwriting Agreements
Plans of Reorganization
Indentures
Material Contracts & Credit Agreements
Subsidiaries Lists
Subsidiaries
Accolade Techologies s.r.o. • MD Insider, Inc. • Accolade 2ndMD LLC • 1stMD LLC • PlushCare, Inc. • PlushCare Technologies Canada, Inc. ...
IRS number
432117836

ACCD stock data

Analyst ratings and price targets

Last 3 months
Current price
Average target
$13.33
Low target
$11.00
High target
$15.00
Raymond James
Initiated
Outperform
$15.00
2 Feb 23
Truist Securities
Maintains
Buy
$14.00
30 Jan 23
Morgan Stanley
Maintains
Equal-Weight
$11.00
6 Jan 23
Latest filings (excl ownership)
View all
8-K
Accolade Announces Results for Fiscal Third Quarter 2023
9 Jan 23
10-Q
2023 Q3
Quarterly report
9 Jan 23
10-Q
2023 Q2
Quarterly report
6 Oct 22
8-K
Accolade Announces Results for Fiscal Second Quarter 2023
6 Oct 22
8-K
Submission of Matters to a Vote of Security Holders
27 Jul 22
8-K
Entry into a Material Definitive Agreement
21 Jul 22
10-Q
2023 Q1
Quarterly report
1 Jul 22
8-K
Accolade Announces Results for Fiscal First Quarter 2023
30 Jun 22
DEF 14A
Definitive proxy
24 Jun 22
S-8
Registration of securities for employees
3 Jun 22
Transcripts
View all
ACCD
Earnings call transcript
2023 Q2
7 Oct 22
ACCD
Earnings call transcript
2023 Q1
1 Jul 22
ACCD
Earnings call transcript
2022 Q4
29 Apr 22
ACCD
Earnings call transcript
2022 Q3
11 Jan 22
ACCD
Earnings call transcript
2022 Q2
8 Oct 21
ACCD
Earnings call transcript
2022 Q1
9 Jul 21
ACCD
Earnings call transcript
2021 Q4
9 May 21
ACCD
Earnings call transcript
2021 Q3
7 Jan 21
ACCD
Earnings call transcript
2021 Q2
14 Oct 20
ACCD
Earnings call transcript
2021 Q1
13 Aug 20
Latest ownership filings
View all
SC 13G/A
BlackRock Inc.
31 Jan 23
4
Stephen H. Barnes
19 Jan 23
4
MICHAEL W HILTON
19 Jan 23
4
Robert N Cavanaugh
19 Jan 23
4
RAJEEV SINGH
19 Jan 23
4
Stephen H. Barnes
6 Jan 23
SC 13G
JPMORGAN CHASE & CO
6 Jan 23
4
Stephen H. Barnes
20 Dec 22
4
RAJEEV SINGH
20 Dec 22
4
MICHAEL W HILTON
20 Dec 22

Financial summary

Financial statements Chart ACCD financial data
Quarter (USD) Nov 22 Aug 22 May 22 Feb 22
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD) Feb 22 Feb 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Cash burn rate (est.) Burn method: Change in cash Burn method: Operating income Burn method: FCF (opex + capex)
Last Q Avg 4Q Last Q Avg 4Q Last Q Avg 4Q
Cash on hand (at last report) 325.64 mm 325.64 mm 325.64 mm 325.64 mm 325.64 mm 325.64 mm
Cash burn (monthly) 1.67 mm 3.36 mm 13.46 mm 38.67 mm 1.56 mm 3.37 mm
Cash used (since last report) 3.83 mm 7.74 mm 30.98 mm 88.99 mm 3.60 mm 7.75 mm
Cash remaining 321.80 mm 317.90 mm 294.66 mm 236.64 mm 322.04 mm 317.88 mm
Runway (months of cash) 193.2 94.6 21.9 6.1 205.9 94.4

Beta Read what these cash burn values mean

Financial data from Accolade earnings reports.

Institutional ownership, Q3 2022

ACCD institutional ownership history Ownership history
81.2% owned by funds/institutions
13F holders Current Prev Q Change
Total holders 148 156 -5.1%
Opened positions 17 35 -51.4%
Closed positions 25 37 -32.4%
Increased positions 56 63 -11.1%
Reduced positions 44 33 +33.3%
13F shares Current Prev Q Change
Total value 632.20 mm 407.11 mm +55.3%
Total shares 59.13 mm 59.60 mm -0.8%
Total puts 300.70 k 180.00 k +67.1%
Total calls 119.00 k 146.50 k -18.8%
Total put/call ratio 2.5 1.2 +105.7%
Largest owners Shares Value Change
JPM JPMorgan Chase & Co. 5.95 mm $67.94 mm -1.2%
Brown Advisory 5.94 mm $67.86 mm -1.4%
ARK Investment Management 5.92 mm $67.59 mm -5.3%
BLK Blackrock 4.84 mm $55.30 mm +4.7%
Vanguard 4.42 mm $50.43 mm +8.0%
Andreessen Horowitz Fund IV 3.78 mm $0.00 0.0%
AH Equity Partners IV 3.78 mm $43.16 mm 0.0%
BLVGF Bellevue 3.57 mm $40.79 mm -1.7%
Rock Springs Capital Management 2.27 mm $25.97 mm +3.4%
Millennium Management 1.70 mm $19.45 mm -20.0%
Largest transactions Shares Bought/sold Change
STT State Street 0.00 -1.36 mm EXIT
PFG Principal Financial Group Inc - Registered Shares 14.45 k -562.83 k -97.5%
Point72 Asset Management 557.94 k +557.94 k NEW
Citadel Advisors 542.61 k +525.39 k +3051.0%
Millennium Management 1.70 mm -424.84 k -20.0%
ARK Investment Management 5.92 mm -331.91 k -5.3%
Vanguard 4.42 mm +328.43 k +8.0%
Woodline Partners 298.77 k +298.77 k NEW
IVZ Invesco 333.78 k +290.69 k +674.6%
Fred Alger Management 438.89 k +259.89 k +145.2%
Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

ACCD insider ownership history Insider history
Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
18 Jan 23 Singh Rajeev Common Stock Sell Dispose S No No 9.9634 276 2.75 k 153,865
18 Jan 23 Cavanaugh Robert N Common Stock Sell Dispose S No No 9.9634 176 1.75 k 144,796
18 Jan 23 Michael W Hilton Common Stock Sell Dispose S No No 9.9634 99 986.38 129,735
18 Jan 23 Stephen H. Barnes Common Stock Sell Dispose S No No 9.9634 138 1.37 k 123,237
17 Jan 23 Singh Rajeev Common Stock Option exercise Acquire M No No 0 932 0.00 154,141
17 Jan 23 Singh Rajeev RSU Common Stock Option exercise Dispose M No No 0 932 0.00 27,053
17 Jan 23 Cavanaugh Robert N Common Stock Option exercise Acquire M No No 0 510 0.00 144,972
17 Jan 23 Cavanaugh Robert N RSU Common Stock Option exercise Dispose M No No 0 510 0.00 14,790
17 Jan 23 Michael W Hilton Common Stock Option exercise Acquire M No No 0 331 0.00 129,834
17 Jan 23 Michael W Hilton RSU Common Stock Option exercise Dispose M No No 0 331 0.00 9,619
Data from 3, 4 and 5 filings. Values as filed, not updated for current price.

News

From Benzinga Pro
Analyst Initiates Coverage On Accolade, Says 'Differentiated In Growing Market'
2 Feb 23
Benzinga's Top Ratings Upgrades, Downgrades For February 2, 2023
2 Feb 23
Raymond James Initiates Coverage On Accolade with Outperform Rating, Announces Price Target of $15
2 Feb 23
Raymond James analyst John Ransom initiates coverage on Accolade (NASDAQ:ACCD) with a Outperform rating and announces Price Target of $15.
Truist Securities Maintains Buy on Accolade, Raises Price Target to $14
30 Jan 23
Analysts Stay Bullish On Accolade Stock, Call Q3 Earnings Better Than Expected Amid Challenging Backdrop
10 Jan 23

Press releases

From Benzinga Pro
Blue Shield of California Launches Virtual Blue Benefit Plan Incorporating Primary, Mental Health, and Specialty Care
30 Jan 23
The nonprofit health plan teams up with Accolade and TeleMed2U to connect members to virtual and in-person care through a new, virtual-first plan. OAKLAND, Calif., Jan. 30, 2023 /PRNewswire/ -- Blue Shield of California
Accolade Announces Results for Fiscal Third Quarter 2023
9 Jan 23
Fiscal third quarter 2023 revenue of $90.9 million, a 9% increase compared to fiscal third quarter 2022 revenue of $83.5 million SEATTLE, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ:ACCD) today
Accolade Champions Health Equity and Welcomes FOLX Health to Trusted Partner Ecosystem at HLTH 2022
14 Nov 22
Chief Medical Officer Dr. Shantanu Nundy and Dr. Jay Bhatt, Managing Director at Deloitte, explore the role of employers in removing barriers to equitable healthcare; Accolade welcomes a new trusted partner serving
Finsight
Resources
  • Knowledgebase
  • Log In
  • Register
Company
  • About
  • Contact
  • Solutions
Products
  • Deal Roadshow
  • DealVDR
  • Evercall
  • Finsight.com
CapEdge
  • Earnings Calendar
  • Earnings Transcripts
  • EDGAR Filing Screener
  • IPO Calendar
  • Compliance
  • Privacy
  • Security
  • Terms
AngelList LinkedIn